heroin and Bipolar-Disorder

heroin has been researched along with Bipolar-Disorder* in 3 studies

Reviews

2 review(s) available for heroin and Bipolar-Disorder

ArticleYear
Chronic heroin use disorder and the brain: Current evidence and future implications.
    Progress in neuro-psychopharmacology & biological psychiatry, 2021, 12-20, Volume: 111

    The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the relationship between chronic heroin use disorder and the brain through a narrative review. A broad range of areas was considered including causal mechanisms, cognitive and neurological consequences of chronic heroin use and novel neuroscience-based clinical interventions. Chronic heroin use is associated with limited or very limited evidence of impairments in memory, cognitive impulsivity, non-planning impulsivity, compulsivity and decision-making. Additionally, there is some evidence for certain neurological disorders being caused by chronic heroin use, including toxic leukoencephalopathy and neurodegeneration. However, there is insufficient evidence on whether these impairments and disorders recover after abstinence. Whilst there is a high prevalence of comorbid psychiatric disorders, there is no clear evidence that chronic heroin use per se causes depression, bipolar disorder, PTSD and/or psychosis. Despite the growing burden on society from heroin use, knowledge of the long-term effects of chronic heroin use disorder on the brain remains limited. Nevertheless, there is evidence for progress in neuroscience-based interventions being made in two areas: assessment (cognitive assessment and neuroimaging) and interventions (cognitive training/remediation and neuromodulation). Longitudinal studies are needed to unravel addiction and neurotoxic mechanisms and clarify the role of pre-existing psychiatric symptoms and cognitive impairments.

    Topics: Bipolar Disorder; Brain; Cognitive Dysfunction; Comorbidity; Heroin; Humans; Impulsive Behavior; Neuroimaging; Neurosciences; Opioid-Related Disorders; Psychotic Disorders

2021
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence.
    The American journal of psychiatry, 1985, Volume: 142, Issue:11

    Recent clinical observations and psychiatric diagnostic findings of drug-dependent individuals suggest that they are predisposed to addiction because they suffer with painful affect states and related psychiatric disorders. The drugs that addicts select are not chosen randomly. Their drug of choice is the result of an interaction between the psychopharmacologic action of the drug and the dominant painful feelings with which they struggle. Narcotic addicts prefer opiates because of their powerful muting action on the disorganizing and threatening affects of rage and aggression. Cocaine has its appeal because of its ability to relieve distress associated with depression, hypomania, and hyperactivity.

    Topics: Adult; Affective Symptoms; Aggression; Bipolar Disorder; Choice Behavior; Cocaine; Depressive Disorder; Heroin; Heroin Dependence; Humans; Male; Mental Disorders; Narcotics; Opioid-Related Disorders; Psychiatric Status Rating Scales; Psychoanalytic Theory; Rage; Self Medication

1985

Other Studies

1 other study(ies) available for heroin and Bipolar-Disorder

ArticleYear
The long-term outcomes of heroin dependent-treatment-resistant patients with bipolar 1 comorbidity after admission to enhanced methadone maintenance.
    Journal of affective disorders, 2013, Volume: 151, Issue:2

    The aim of this study was to compare the long-term outcomes of treatment-resistant bipolar 1 heroin addicts with peers who were without DSM-IV axis I psychiatric comorbidity (dual diagnosis).. 104 Heroin-dependent patients (TRHD), who also met criteria for treatment resistance - 41 of them with DSM-IV-R criteria for Bipolar 1 Disorder (BIP1-TRHD) and 63 without DSM-IV-R axis I psychiatric comorbidity (NDD-TRHD) - were monitored prospectively (3 years on average, min. 0.5, max. 8) along a Methadone Maintenance Treatment Programme (MMTP).. The rates for survival-in-treatment were 44% for NDD-TRHD patients and 58% for BIP1-TRHD patients (p=0.062). After 3 years of treatment such rates tended to become progressively more stable. BIP1-TRHD patients showed better outcome results than NDD-TRHD patients regarding CGI severity (p<0.001) and DSM-IV GAF (p<0.001). No differences were found regarding urinalyses for morphine between groups during the observational period. Bipolar 1 patients needed a higher methadone dosage in the stabilization phase, but this difference was not statistically significant.. The observational nature of the protocol, the impossibility of evaluating a follow-up in the case of the patients who dropped out, and the multiple interference caused by interindividual variability, the clinical setting and the temporary use of adjunctive medications.. Contrary to expectations, treatment-resistant patients with bipolar 1 disorder psychiatric comorbidity showed a better long-term outcome than treatment-resistant patients without psychiatric comorbidity.

    Topics: Adult; Bipolar Disorder; Diagnosis, Dual (Psychiatry); Female; Heroin; Heroin Dependence; Humans; Male; Methadone; Narcotics; Opiate Substitution Treatment; Prospective Studies; Treatment Outcome; Young Adult

2013